BPC-157 vs Teriparatide

Extensively Studied vs Extensively Studied
compatible Different mechanisms; no known interactions.

Molecular Data

BPC-157 Teriparatide
Weight 1,419.53 Da 4,118 Da
Half-life <30 minutes ~1 hour (subcutaneous); ~5 minutes (intravenous)
Chain 15 amino acids 34 amino acids
Type Pentadecapeptide Recombinant PTH fragment

Key Benefits

BPC-157
01 Accelerated tendon, ligament, muscle, and bone healing
02 Localized tissue repair with direct targeting
03 Superior bioavailability
04 Anti-inflammatory effects
05 Angiogenesis promotion
06 Gastric and intestinal protection
Teriparatide
01 FDA-approved for osteoporosis treatment
02 Actively builds new bone (anabolic)
03 Increases spine bone density by 5-9%
04 Reduces vertebral fracture risk by 65%
05 Reduces nonvertebral fractures by 35%
06 Works differently than antiresorptive drugs
07 Benefits seen within 3 months
08 Creates 'anabolic window' for bone growth

Dosing Protocols

BPC-157
250-500mcg / Once or twice daily
Tendon/Joint healing 250-500 mcg 1-2x daily
Serious injury 500-1000 mcg 2x daily
General healing 250-500 mcg 1-2x daily
Maintenance 250 mcg 1x daily
Teriparatide
20mcg daily (FDA-approved dose) / Once daily at same time each day
Osteoporosis treatment 20 mcg Once daily

Side Effects

BPC-157
Mild injection site redness
Injection site irritation
Possible mild digestive adjustment (oral)
Teriparatide
Injection site reactions
Nausea
Headache
Leg cramps
Dizziness
Joint pain
Contraindications
Active cancer (due to angiogenic effects)
Pregnancy or breastfeeding
Blood thinners (consult doctor due to angiogenesis)
WADA prohibited for competitive athletes
Paget's disease of bone
Prior skeletal radiation therapy
History of skeletal malignancies
Metabolic bone diseases other than osteoporosis
Pre-existing hypercalcemia
Pregnancy

Research Evidence

BPC-157 Teriparatide
Status Extensively Studied Extensively Studied
References 6 studies 4 studies
Latest January 2025
FDA Approved No Yes

This comparison is for educational and research purposes only. Consult a healthcare professional before use.